# CLOFARABINE
> **ANDA210283** · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2018-12-27
## Drug
- **FDA Application Number:** ANDA210283
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOFARABINE
- **Generic name:** Clofarabine
- **Active ingredients:** CLOFARABINE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** HOSPIRA
- **First approval:** 2018-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210283)
---
*AI Analytics · CC0 1.0*